Suven Pharmaceuticals Limited
NSE:SUVENPHAR.NS
1,249.95 (INR) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Suven Pharmaceuticals Limited |
Symbool | SUVENPHAR.NS |
Munteenheid | INR |
Prijs | 1,249.95 |
Beurswaarde | 318,193,521,750 |
Dividendpercentage | 0% |
52-weken bereik | 541 - 1,287.9 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Venkateswarlu Jasti M.Pharm. M.S. |
Website | https://www.suvenpharm.com |
An error occurred while fetching data.
Over Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)